Pharmaceutical Particle Engineering & Delivery Laboratory
03/04/2024 Congratulations to Maizbha for his research paper "Tobramycin reduces pulmonary toxicity of polymyxin B via inhibiting the megalin-mediated drug uptake in the human lung epithelial cells" being accepted in Pharmaceutics.
02/01/2024 Our group received a five-year R01 grant with $2.4M funding from NIH/NHLBI. Prof Zhou is the contact PD/PI of this multi-national research project with a title "Aerosol delivery of combinational therapeutics targeting deadly lung infections". https://www.imph.purdue.edu/news/2024/03/01/professor-tony-zhou-awarded-24m-nih-grant-lead-multi-national-team-fighting-global
1/24/2024 Congratulations to Yijing Huang for her research paper "Liposomal formulation reduces transport and cell uptake of colistin in human lung epithelial Calu-3 cell and 3D human lung primary tissue models" being accepted in AAPS PharmSciTech. https://link.springer.com/article/10.1208/s12249-024-02753-6
12/8/2023 Congratulations to Kinnari Arte for her research paper "Understanding the impact of mannitol on physical stability and aerosolization of spray-dried protein powders for inhalation" being accepted in International Journal of Pharmaceutics. https://www.sciencedirect.com/science/article/abs/pii/S0378517323011201
Qi (Tony) Zhou
University Faculty Scholar Associate Professor, Department of Industrial and molecular Pharmaceutics, College of Pharmacy
Purdue University
University Faculty Scholar Associate Professor, Department of Industrial and molecular Pharmaceutics, College of Pharmacy
Purdue University
